Industry Verticals »

All Categories

Insights »

About TMR »

Artificial Vital Organs and Medical Bionics Market

Artificial Vital Organs and Medical Bionics Market (Artificial Heart, Kidney, Liver, Pancreas & Lungs, Ear Bionics, Vision Bionics, Exoskeletons, Bionic Limbs, Brain Bionics and Cardiac Bionics) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

With major developments in the field of healthcare technology, organ transplantation has become a realistic surgical approach to cater to the needs of patients suffering from acute organ failure. As the number of patients waiting for organ transplant is increasing along with the lack of availability of donor organs, the demand for artificial organs has increased in the market. With years of technological advancement, artificial organs have been efficiently established as a potential alternative for organ transplantation. At present, artificial organs are being successfully used as a bridge-to-transplant and some of them are also used as destination therapy. In addition, as the number of cases of occupational and age-related disabilities is increasing, the demand for viable patient rehabilitation options is also on the rise.

Medical bionics deals with the incorporation of electronics and mechanics in biology so as to replace the functioning of limbs or other organs. With intensive R&D and evolution of technology in devices such as bionic hand, vision bionics, total artificial heart, ventricular assist devices and others, artificial vital organs and medical bionics will prove to be a viable substitute for the impending donor organ scarcity and the increase in demand for efficient patient rehabilitation for the disabled.

Due to an increase in the number of product approvals for artificial vital organs and medical bionics, the market for these devices will witness an increase in the rate of artificial organ transplantation and patient rehabilitation. The new and advanced artificial organs and bionic devices such as total artificial heart, artificial liver support devices, bionic limbs, ear and vision bionics, with their increased biocompatibility, safety and shelf life, will assist in prolonging the life of patients and improving their life. Furthermore, introduction of new products in the market aiding different diseased human organs and other bodily functions will play a pivotal role in the future growth of this market.

The market for artificial kidneys forms the largest segment in the artificial vital organs market. Increase in prevalence of cases of acute renal failure in developed nations has resulted into the increase in use of hemodialysis machines in the market. In addition, increased instances of disabilities, accidents and injuries resulting in amputations are one of the major factors augmenting the demand for medical bionics in the healthcare industry. Moreover, rising healthcare expenditure and better patient outcomes will spur the growth of this market in emerging economies. However, ethical criticism associated with organ transplant, high cost of medical bionics and vague reimbursement policies are the major factors which may restrain the growth of this market. On the other hand, potential scope of introducing artificial organs as a therapeutic option serves as a future growth opportunity for this market.

Geographically, North America leads the artificial vital organs and medical bionics market and is followed by Europe. The large pool of aging population and resultant high prevalence of disabilities and organ failures are the major factors responsible for driving the demand for these products in North America and Europe. However, in the future, it is expected that due to factors such as development of healthcare infrastructure, rising healthcare expenditure, increase in awareness about personal wellbeing and availability of better healthcare facilities, the market for artificial vital organs and medical bionics in Asia-Pacific will increase in the future.

The major players in the global artificial vital organs and medical bionics market include companies such as Abbott Diabetes Care, Inc., Asahi Kasei Medical Co., Ltd., Baxter International, Inc., Edwards Lifesciences Corporation, Ekso Bionics, iWalk, Inc., Jarvik Heart, Inc., Nikkiso Co., Ltd., Ossur Hf, Ottobock Healthcare GmbH and others.

    Table of Contents

    1. Introduction

        1.1. Report Description

        1.2. Market Segmentation

        1.3. Research Methodology

        1.4. List of Abbreviations

    2. Executive Summary

    3. Global Artificial Vital Organs and Medical Bionics Market Overview

        3.1. Introduction

        3.2. Market Trends and Future Outlook

        3.3. Market Drivers

            3.3.1. Increase in Prevalence of Organ Failure and Disabilities

            3.3.2. Increase in the Number of Patients for Organ Transplant and Lack Of Donor Organs

        3.4. Market Restraints

            3.4.1. Criticism Associated with Artificial Organ Transplant

            3.4.2. High Cost Involved in Development of Artificial Organs and Medical Bionics

        3.5. Market Opportunities

            3.5.1. Scope Of Artificial Organs in Therapeutics

        3.6. Porter’s Five Force Analysis: Global Artificial Vital Organs & Medical Bionics Market

            3.6.1. Bargaining Power of Suppliers

            3.6.2. Bargaining Power of Buyers

            3.6.3. Threat from Substitutes

            3.6.4. Threat of New Entrants

            3.6.5. Degree of Competitive Rivalry

        3.7. Market Attractiveness Analysis: Global Artificial Vital Organs and Medical Bionics Market, By Geography

    4. Global Artificial Vital Organs and Medical Bionics Market, By Product Type

        4.1. Overview

        4.2. Artificial Vital Organs Market

            4.2.1. Artificial Heart

                4.2.1.1. Total Artificial Heart (TAH)

            4.2.2. Artificial Kidney

                4.2.2.1. Hemodialysis Machines

            4.2.3. Artificial Liver

            4.2.4. Artificial Pancreas

                4.2.4.1. Insulin Pumps

            4.2.5. Artificial Lungs

                4.2.5.1. Heart-Lung Bypass Machines

                4.2.5.2. Oxygenators

        4.3. Bionics Market

            4.3.1. Ear Bionics (Cochlear Implants)

            4.3.2. Vision Bionics

            4.3.3. Exoskeletons

            4.3.4. Bionic Limbs

                4.3.4.1. Bionic Leg

                4.3.4.2. Bionic Hand

            4.3.5. Brain Bionics

                4.3.5.1. Spinal Cord Stimulators

                4.3.5.2. Deep Brain Stimulators

                4.3.5.3. Vagus Nerve Stimulators

            4.3.6. Cardiac Bionics

                4.3.6.1. Ventricular Assist Device (VAD)

                4.3.6.2. Left Ventricular Assist Device (LVAD)

                4.3.6.3. Right Ventricular Assist Device (RVAD)

                4.3.6.4. Heart Valves

                    4.3.6.4.1. Mechanical Heart Valves

                    4.3.6.4.2. Biological Tissue Valves

                    4.3.6.4.3. Transcatheter Heart Valves

    5. Global Artificial Vital Organs and Medical Bionics Market, By Geography

        5.1. Introduction

        5.2. North America

            5.2.1. North America Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010-2018 (USD Million)

        5.3. Europe

            5.3.1. Europe Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010-2018 (USD Million)

        5.4. Asia-Pacific

            5.4.1. Asia-Pacific Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010-2018 (USD Million)

        5.5. Rest of the World (Row)

            5.5.1. Row Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010-2018 (USD Million)

    6. Competitive Landscape

        6.1. Current Market Scenario and Pipeline Snapshot

    7. Recommendations

        7.1. Market Strategy for Success

        7.2. Barriers to be Considered

            7.2.1. Financial Constraints

            7.2.2. Regulatory Approvals

    8. Company Profiles

        8.1. Abbott Diabetes Care, Inc.

            8.1.1. Company Overview

            8.1.2. Financial Overview

            8.1.3. Product Portfolio

            8.1.4. Strategic Overview

            8.1.5. Recent Developments

        8.2. Abiomed, Inc.

            8.2.1. Company Overview

            8.2.2. Financial Overview

            8.2.3. Product Portfolio

            8.2.4. Strategic Overview

            8.2.5. Recent Developments

        8.3. Asahi Kasei Medical Co., Ltd.

            8.3.1. Company Overview

            8.3.2. Financial Overview

            8.3.3. Product Portfolio

            8.3.4. Strategic Overview

            8.3.5. Recent Developments

        8.4. Baxter International, Inc.

            8.4.1. Company Overview

            8.4.2. Financial Overview

            8.4.3. Product Portfolio

            8.4.4. Strategic Overview

            8.4.5. Recent Developments

        8.5. Cyberonics, Inc.

            8.5.1. Company Overview

            8.5.2. Financial Overview

            8.5.3. Product Portfolio

            8.5.4. Strategic Overview

            8.5.5. Recent Developments

        8.6. Edwards Lifesciences Corporation

            8.6.1. Company Overview

            8.6.2. Financial Overview

            8.6.3. Product Portfolio

            8.6.4. Strategic Overview

            8.6.5. Recent Developments

        8.7. Ekso Bionics

            8.7.1. Company Overview

            8.7.2. Financial Overview

            8.7.3. Product Portfolio

            8.7.4. Strategic Overview

            8.7.5. Recent Developments

        8.8. F. Hoffmann-La Roche Ltd

            8.8.1. Company Overview

            8.8.2. Financial Overview

            8.8.3. Product Portfolio

            8.8.4. Strategic Overview

            8.8.5. Recent Developments

        8.9. Fresenius Medical Care AG & Co. Kgaa

            8.9.1. Company Overview

            8.9.2. Financial Overview

            8.9.3. Product Portfolio

            8.9.4. Strategic Overview

            8.9.5. Recent Developments

        8.10. Gambro AB

            8.10.1. Company Overview

            8.10.2. Financial Overview

            8.10.3. Product Portfolio

            8.10.4. Strategic Overview

            8.10.5. Recent Developments

        8.11. Iwalk, Inc.

            8.11.1. Company Overview

            8.11.2. Financial Overview

            8.11.3. Product Portfolio

            8.11.4. Strategic Overview

            8.11.5. Recent Developments

        8.12. Jarvik Heart, Inc.

            8.12.1. Company Overview

            8.12.2. Financial Overview

            8.12.3. Product Portfolio

            8.12.4. Strategic Overview

            8.12.5. Recent Developments

        8.13. Medtronic, Inc.

            8.13.1. Company Overview

            8.13.2. Financial Overview

            8.13.3. Product Portfolio

            8.13.4. Strategic Overview

            8.13.5. Recent Developments

        8.14. Micromed Cardiovascular, Inc.

            8.14.1. Company Overview

            8.14.2. Financial Overview

            8.14.3. Product Portfolio

            8.14.4. Strategic Overview

            8.14.5. Recent Developments

        8.15. Nikkiso Co., Ltd.

            8.15.1. Company Overview

            8.15.2. Financial Overview

            8.15.3. Product Portfolio

            8.15.4. Strategic Overview

            8.15.5. Recent Developments

        8.16. Ossur Hf

            8.16.1. Company Overview

            8.16.2. Financial Overview

            8.16.3. Product Portfolio

            8.16.4. Strategic Overview

            8.16.5. Recent Developments

        8.17. Ottobock Healthcare Gmbh

            8.17.1. Company Overview

            8.17.2. Financial Overview

            8.17.3. Product Portfolio

            8.17.4. Strategic Overview

            8.17.5. Recent Developments

        8.18. Second Sight Medical Products, Inc.

            8.18.1. Company Overview

            8.18.2. Financial Overview

            8.18.3. Product Portfolio

            8.18.4. Strategic Overview

            8.18.5. Recent Developments

        8.19. Syncardia Systems, Inc.

            8.19.1. Company Overview

            8.19.2. Financial Overview

            8.19.3. Product Portfolio

            8.19.4. Strategic Overview

            8.19.5. Recent Developments

        8.20. Thoratec Corporation

            8.20.1. Company Overview

            8.20.2. Financial Overview

            8.20.3. Product Portfolio

            8.20.4. Strategic Overview

            8.20.5. Recent Developments

        8.21. Touch Bionics, Inc.

            8.21.1. Company Overview

            8.21.2. Financial Overview

            8.21.3. Product Portfolio

            8.21.4. Strategic Overview

            8.21.5. Recent Developments

        8.22. Vital Therapies, Inc.

            8.22.1. Company Overview

            8.22.2. Financial Overview

            8.22.3. Product Portfolio

            8.22.4. Strategic Overview

            8.22.5. Recent Developments

        8.23. Worldheart Corporation

            8.23.1. Company Overview

            8.23.2. Financial Overview

            8.23.3. Product Portfolio

            8.23.4. Strategic Overview

            8.23.5. Recent Developments

    List of Tables

    TABLE 1: Market Snapshot: Global Artificial Vital Organs and Medical Bionics Market

    TABLE 2: Global Artificial Vital Organs and Medical Bionics Market, By Product Type, Size and Forecast, 2010-2018 (USD Million)

    TABLE 3: Global Artificial Lungs Market, By Product Type, Size and Forecast, 2010-2018 (USD Million)

    TABLE 4: Global Medical Bionics Market, By Product Type, Size and Forecast, 2010-2018 (USD Million)

    TABLE 5: Global Bionic Limbs Market, By Product Type, Size and Forecast, 2010 -2018 (USD Million)

    TABLE 6: Global Brain Bionics Market, By Product Type, Size and Forecast, 2010-2018 (USD Million)

    TABLE 7: Global Cardiac Bionics Market, By Product Type, Size and Forecast, 2010-2018 (USD Million)

    TABLE 8: Global Ventricular Assist Devices (VAD) Market, By Product Type, Size and Forecast, 2010-2018 (USD Million)

    TABLE 9: Global Heart Valves Market, By Product Type, Market Size and Forecast, 2010-2018 (USD Million)

    TABLE 10: Global Artificial Vital Organs And Medical Bionics Market, By Geography, Size and Forecast, 2010-2018 (USD Million)

    TABLE 11: Competitive Landscape: Global Artificial Vital Organs Market

    TABLE 12: Competitive Landscape: Global Medical Bionics Market

    List of Figures

    FIG. 1: Artificial Vital Organs and Medical Bionics: Market Segmentation

    FIG. 2: Global Artificial Vital Organs Market, By Product Type, 2011 (USD Million)

    FIG. 3: Global Medical Bionics Market, By Product Type, 2011 (USD Million)

    FIG. 4: Global Artificial Vital Organs and Medical Bionics Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 5: Porter’s Five Force Analysis: Global Artificial Vital Organs & Medical Bionics Market

    FIG. 6: Market Attractiveness Analysis: Global Artificial Vital Organs and Medical Bionics Market, By Geography

    FIG. 7: Comparative Analysis: Global Artificial Vital Organs Market, By Product Type, 2011 & 2018 (Value %)

    FIG. 8: Global Artificial Vital Organs Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 9: Global Total Artificial Heart (TAH) Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 10: Global Hemodialysis Machines Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 11: Global Artificial Liver Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 12: Global Insulin Pumps Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 13: Global Heart-Lung Bypass Machines Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 14: Global Oxygenators, Market Size and Forecast, 2010-2018 (USD Million)

    FIG. 15: Comparative Analysis: Global Medical Bionics Market, By Product Type, 2011 & 2018 (Value %)

    FIG. 16: Global Ear Bionics (Cochlear Implants) Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 17: Global Vision Bionics Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 18: Global Exoskeletons Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 19: Global Bionic Leg Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 20: Global Bionic Hand Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 21: Global Spinal Cord Stimulators Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 22: Global Deep Brain Stimulators Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 23: Global Vagus Nerve Stimulators Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 24: Global Left Ventricular Assist Device (LVAD) Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 25: Global Right Ventricular Assist Device (RVAD) Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 26: Global Mechanical Heart Valves Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 27: Global Biological Tissue Valves Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 28: Global Transcatheter Heart Valves Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 29: Comparative Analysis: Global Artificial Vital Organs and Medical Bionics Market, By Geography, 2011 & 2018 (Value %)

    FIG. 30: North America Artificial Vital Organs And Medical Bionics Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 31: Europe Artificial Vital Organs And Medical Bionics Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 32: Asia-Pacific Artificial Vital Organs And Medical Bionics Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 33: Row Artificial Vital Organs And Medical Bionics Market, Size and Forecast, 2010-2018 (USD Million)

    FIG. 34: Abbott Diabetes Care, Inc.: Annual Revenues, 2010-2012 (USD Million)

    FIG. 35: Abiomed, Inc.: Annual Revenues, 2010-2012 (USD Million)

    FIG. 36: Asahi Kasei Corporation (Healthcare Segment): Annual Revenues, 2010-2012 (USD Million)

    FIG. 37: Baxter International, Inc.: Annual Revenues, 2010-2012 (USD Million)

    FIG. 38: Cyberonics, Inc.: Annual Revenues, 2010-2012 (USD Million)

    FIG. 39: Edwards Lifesciences Corporation: Annual Revenues, 2010-2012 (USD Million)

    FIG. 40: F. Hoffmann-La Roche Ltd: Annual Revenues, 2010-2012 (USD Million)

    FIG. 41: Fresenius Medical Care AG & Co. Kgaa: Annual Revenues, 2010-2012 (USD Million)

    FIG. 42: Medtronic, Inc.: Annual Revenues, 2010-2012 (USD Million)

    FIG. 43: Nikkiso Co. Ltd.: Annual Revenues, 2010-2012 (USD Million)

    FIG. 44: Ossur Hf: Annual Revenues, 2010-2012 (USD Million)

    FIG. 45: Thoratec Corporation: Annual Revenues, 2010-2012 (USD Million)

Copyright © Transparency Market Research, Inc. All Rights reserved

Artificial Vital Organs and Medical Bionics Market

Schedule a Call